Literature DB >> 546789

Protection against experimental cholera by oral or parenteral immunization.

J W Peterson.   

Abstract

Comparisons were made between the antigenic potency and protective capacity of several cholera toxin derivatives. Rabbits were immunized parenterally with 50 microgram of cholera toxin, A subunit, B subunit, procholeragenoid, or Wyeth glutaraldehyde toxoid 20101. Examination of the antibody response curves revealed that cholera toxin elicited serum antitoxin responses that rose more quickly than in the subunit-immunized animals; however, antitoxin levels were of the same magnitude after 10 weeks. Parenteral immunization with procholeragenoid evoked antibody titers that were similar to the toxin, whereas Wyeth toxoid yielded only one-tenth the level of antitoxin. Oral immunization with procholeragenoid as well as Wyeth toxoid resulted in lower serum antitoxin titers than that achieved with parenteral immunization, despite the oral administration of 10 times the parenteral dose. Analysis of protection against live-cell challenge revealed that parenteral administration of procholeragenoid provided the best protection against fluid accumulation. Oral immunization with procholeragenoid also was very effective, whereas oral immunization with B subunit or Wyeth toxoid resulted in minimal protection. Also, the A subunit provided surprisingly more protection than did cholera toxin.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 546789      PMCID: PMC414658          DOI: 10.1128/iai.26.2.594-598.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  Synergistic protective effect in rabbits of immunization with Vibrio cholerae lipopolysaccharide and toxin/toxoid.

Authors:  A M Svennerholm; J Holmgren
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

2.  Covalent structure of the beta chain of cholera enterotoxin.

Authors:  A Kurosky; D E Markel; J W Peterson
Journal:  J Biol Chem       Date:  1977-10-25       Impact factor: 5.157

3.  Development of a purified cholera toxoid. III. Refinements in purification of toxin and methods for the determination of residual somatic antigen.

Authors:  R S Rappaport; W A Pierzchala; G Bonde; T McCann; B A Rubin
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

4.  Development of improved cholera vaccine based on subunit toxoid.

Authors:  J Holmgren; A M Svennerholm; I Lönnroth; M Fall-Persson; B Markman; H Lundbeck
Journal:  Nature       Date:  1977-10-13       Impact factor: 49.962

5.  Characterization of the antigenic determinants of cholera toxin subunits.

Authors:  D E Markel; K E Hejtmancik; J W Peterson; F B Martin; A Kurosky
Journal:  Infect Immun       Date:  1979-08       Impact factor: 3.441

6.  Preparation of a purified antigenic cholera toxoid.

Authors:  R Germanier; E Fürer; S Varallyay; T M Inderbitzin
Journal:  Infect Immun       Date:  1976-06       Impact factor: 3.441

7.  Synergistic protection against experimental cholera by immunization with cholera toxoid and vaccine.

Authors:  J W Peterson
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

8.  Toward the development of a standard reference cholera antitoxin.

Authors:  J B Craig
Journal:  Dev Biol Stand       Date:  1978

9.  Antigenic specificity of neutralizing antibody to cholera toxin.

Authors:  J W Peterson; K E Hejtmancik; D E Markel; J P Craig; A Kurosky
Journal:  Infect Immun       Date:  1979-06       Impact factor: 3.441

10.  Radioimmunoassay for the antigenic determinants of cholera toxin and its components.

Authors:  K E Hejtmancik; J W Peterson; D E Markel; A Kurosky
Journal:  Infect Immun       Date:  1977-09       Impact factor: 3.441

View more
  12 in total

1.  Comparison of the reactivities and immunogenicities of procholeragenoid and the B subunit of cholera toxin in Thai volunteers.

Authors:  S Migasena; P Pitisuttitham; P Suntharasamai; B Prayurahong; W Supanaranond; V Desakorn; R E Black
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

Review 2.  New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development.

Authors:  M M Levine; J B Kaper; R E Black; M L Clements
Journal:  Microbiol Rev       Date:  1983-12

3.  Safety, immunogenicity, and efficacy against cholera challenge in humans of a typhoid-cholera hybrid vaccine derived from Salmonella typhi Ty21a.

Authors:  C O Tacket; B Forrest; R Morona; S R Attridge; J LaBrooy; B D Tall; M Reymann; D Rowley; M M Levine
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

4.  Monoclonal immunoglobulin A antibodies directed against cholera toxin prevent the toxin-induced chloride secretory response and block toxin binding to intestinal epithelial cells in vitro.

Authors:  F M Apter; W I Lencer; R A Finkelstein; J J Mekalanos; M R Neutra
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

5.  Oral immunization of dogs with purified cholera toxin, crude cholera toxin, or B subunit: evidence for synergistic protection by antitoxic and antibacterial mechanisms.

Authors:  N F Pierce; W C Cray; J B Sacci
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

6.  Procholeragenoid: a safe and effective antigen for oral immunization against experimental cholera.

Authors:  N F Pierce; W C Cray; J B Sacci; J P Craig; R Germanier; E Fürer
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

7.  Serum antibody responses of juvenile and infant rhesus monkeys injected with Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-protein conjugates.

Authors:  R Schneerson; J B Robbins; C Chu; A Sutton; W Vann; J C Vickers; W T London; B Curfman; M C Hardegree; J Shiloach
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

8.  Preparation of procoligenoids from Escherichia coli heat-labile enterotoxins.

Authors:  R A Finkelstein; C V Sciortino; L C Rieke; M F Burks; M Boesman-Finkelstein
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

9.  Immunization with cholera toxin B subunit induces high-level protection in the suckling mouse model of cholera.

Authors:  Gregory A Price; Kim McFann; Randall K Holmes
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

10.  Respective contributions to protection of primary and booster immunization with Escherichia coli heat-labile enterotoxin in rats.

Authors:  F A Klipstein; R F Engert
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.